These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4914860)

  • 1. [Monoamine oxidase inhibitors: various clinical remarks on phenelzine].
    Guyotat J; Favre-Tissot M; Marie-Cardine M
    J Med Lyon; 1966 Jun; 47(101):1009-15. PubMed ID: 4914860
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phenelzine: legacy or current psychiatric practice?].
    Marini S; Serata D; Brugnoli R
    Clin Ter; 2013; 164(3):e211-22. PubMed ID: 23868641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of IMAO on glycemic equilibrium: potentiation of insulinic hypoglycemia by beta-phenyl-ethyl-hydrazine (Nardil)].
    Patrignani A; Miele V
    G Psichiatr Neuropatol; 1968; 96(1):29-43. PubMed ID: 5712513
    [No Abstract]   [Full Text] [Related]  

  • 4. MAO inhibition and antidepressant activity.
    Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
    Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
    [No Abstract]   [Full Text] [Related]  

  • 5. An open trial of MAO inhibitors in bulimia.
    Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
    J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibitors, their structural analogues, and neuroprotection.
    Sowa BN; Holt A; Todd KG; Baker GB
    Indian J Exp Biol; 2004 Sep; 42(9):851-7. PubMed ID: 15462176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are monoamine-oxidase inhibitors antidepressants?
    Tyrer TP
    Proc R Soc Med; 1973 Sep; 66(9):950-1. PubMed ID: 4805106
    [No Abstract]   [Full Text] [Related]  

  • 9. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical depression.
    Silberman EK; Sullivan JL
    Psychiatr Clin North Am; 1984 Sep; 7(3):535-47. PubMed ID: 6384959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder.
    Westenberg HG; den Boer JA
    Psychopharmacol Bull; 1989; 25(1):119-23. PubMed ID: 2528158
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of psychopharmacological drugs in the aged.
    Webb WL
    Geriatrics; 1971 Jun; 26(6):94-103. PubMed ID: 5087975
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors.
    Masters AB
    Can Med Assoc J; 1971 Dec; 105(12):1281. PubMed ID: 5150330
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine oxidase inhibitors for depressed cardiac patients.
    Lippmann SB; Manshadi MS; Gultekin A
    J Clin Psychiatry; 1985 Dec; 46(12):545-6. PubMed ID: 4066625
    [No Abstract]   [Full Text] [Related]  

  • 16. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 17. Modafinil augmentation of phenelzine for residual fatigue in dysthymia.
    Ashton AK
    Am J Psychiatry; 2004 Sep; 161(9):1716-7. PubMed ID: 15337670
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase inhibitors and neuroprotection: a review.
    Al-Nuaimi SK; Mackenzie EM; Baker GB
    Am J Ther; 2012 Nov; 19(6):436-48. PubMed ID: 22960850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoamine oxidase and essential arterial hypertension].
    Sicuteri F; Del Bene E; Anselmi B; Del Bianco PL
    Boll Soc Ital Biol Sper; 1967 Sep; 43(17):1055-8. PubMed ID: 6077438
    [No Abstract]   [Full Text] [Related]  

  • 20. Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
    Pohl R; Berchou R; Rainey JM
    J Clin Psychopharmacol; 1982 Dec; 2(6):399-407. PubMed ID: 7174863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.